The 'two-week' target for the diagnosis of pancreatic carcinoma: An achievable aim?

European Journal of Surgical Oncology

Volumn 29, Issue 7, 2003, Pages 575-579

  Gilliam, A D ^a   Lobo, D N ^a   Rowlands, B J ^a   Beckingham, I J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Cancer; Diagnosis; Jaundice; Pancreas; Survival; Two week rule

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOSCOPIC THERAPY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TEACHING HOSPITAL; TIME; UNIVERSITY HOSPITAL;

EID: 0141793004     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00112-4     Document Type: Article

References (23)

1. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J (eds) Cancer Incidence in Five Continents, vol. VI. Lyon: International Agency for Research on Cancer, 1992. IARC Scientific Publ No. 120.
2. Fernandez E, La Vecchia C, Porta M, Negri E, Lucchini F, Levi F. Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer 1994; 57: 786-92.
3. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemus JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111-5.
4. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987; 60: 2284-303.
5. Office of Population Censuses and Surveys: Mortality statistics. Cause: Review of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales. Series DH2, No. 19, London: HMSO, 1992.
6. Carter DC. Cancer of the pancreas. Gut 1990; 31: 494-6.
7. Cancer Registry of Norway, Cancer Registry of Norway: Survival of Cancer Patients. Cases Diagnosed in Norway 1968-75. Oslo: Cancer Registry of Norway, 1980.
8. Baulieux J, Delpero JR. Surgical treatment of pancreatic cancer: curative resections. Ann Chir 2000; 125: 609-17.
9. Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. In: De Vita VT Jr, Hellman S, Rosenburg SA (eds) Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: Lippincott, 1993: 849-82.
10. Bluemke DA, Cameron JL, Hruban RH, Pitt HA, Siegelman SS, Soyer P, Fishman EK. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 1995; 197: 381-5.
11. Safi F, Roscher R, Beger HG. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma. Bull Cancer 1990; 77: 83-91.
12. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI. A new strategy for the application of CA 19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999; 94: 1941-6.
13. Ritts RE, Pitt HA. CA 19-9 in pancreatic cancer. Surg Oncol Clin N Am 1998; 7: 93-101.
14. Cowling MG, Adam AN. Internal stenting in malignant biliary obstruction. World J Surg 2001; 25: 355-9.
15. Conio M, Demarquay JF, De Luca L, Marchi S, Dumas R. Endosciopic treatment of pancreatico-biliary malignancies. Crit Rev Oncol Hematol 2001; 37: 127-35.
16. Warren KW, Christophi C, Armendariz R, Basu S. Current trends in the diagnosis and treatment of carcinoma of the pancreas. Am J Surg 1983; 145: 813-8.
17. Tamm E, Charnsangavej C. Pancreatic cancer: current concepts in imaging for diagnosis and staging. Cancer J 2001; 7: 298-311.
18. Guidance on the use of gemcitabine for the treatment of pancreatic cancer. Technology Appraisal Guidance No. 25. London: National Institute for Clinical Excellence; 2001 (http://www.nice.org.uk/pdf/ gemcitabineguidance.pdf).
19. Carmichael J. Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. Digestion 1997; 58: 503-7.
20. Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-13.
21. Yamaguchi K, Nishihara K, Tsuneyoshi M. Non-icteric pancreas head carcinoma fares worse than icteric pancreas head carcinoma. J Surg Oncol 1992; 49: 253-8.
22. Kairaluoma MI, Myllyla V, Partio E, Stahlberg M, Laitinen S, Junonen T, Suramo I. Impact of new imaging techniques on survival in cancer of the head of the pancreas and the periampullary region. Acta Chir Scand 1985; 151: 69-72.
23. Parks RW, Johnston GW, Rowlands BJ. Surgical bypass for benign and malignant extrahepatic biliary tract disease. Br J Surg 1997; 84: 488-92.